白癜風(fēng)的流行病學(xué)病因?qū)W調(diào)查及導(dǎo)師治驗(yàn)
[Abstract]:This paper mainly includes three parts: literature review, clinical investigation and tutor treatment experience.
Literature review: from two angles of modern medicine and traditional medicine, this paper expounds the general situation of the research on the etiology and treatment progress of vitiligo, including the latest research on the pathogenesis of vitiligo at home and abroad, the progress in the treatment of treatment and the achievements of clinical research in recent years, the understanding of the pathogenesis of vitiligo in traditional Chinese medicine, and the recent modern people Clinical experience and experience in the treatment of vitiligo in recent years.
Clinical research research part:
Objective: through the epidemiological investigation of vitiligo patients in Department of Dermatology of Beijing Chinese Medicine Hospital during the period of December 2011 June 2011, the epidemiological data of vitiligo, including sex, age, course of disease, disease season, skin color, location and size of skin lesions, and the distribution of clinical types, were mainly included. Conditions, family history, associated history, common cause, inducement and possible related risk factors, tongue coating, pulse image, TCM syndrome differentiation, and so on. On this basis, we summarize the age of vitiligo, the incidence of men and women has no difference, the average course of disease, the skin lesions have no good hair position and seasonal regularity; the incidence of various types of clinical types; The relationship between vitiligo and other diseases, the familial hereditary tendency, the clinical common cause, the inducing factor and the possible related risk factors, the tongue coating pulse and the pattern of TCM syndrome differentiation, provide some research basis and thought for the research of the etiology and treatment of vitiligo in the future.
Methods: formulating the epidemiological etiological questionnaire for vitiligo, collecting the cases after their informed consent, carefully filling out the data of the form and respecting the patient's right to privacy. After collecting all the cases, the data were concentrated. All the data were entered into the Excel form and used in the SPSS17.0 software. Statistics were processed, and corresponding conclusions were obtained. Counting data were described by mean, standard deviation, and measured data were described by constituent ratio.
Results: a total of 104 patients with vitiligo were collected, 75 women, 29 male and female: male was 2.6:1. The incidence of vitiligo in women was higher than that of men. The first onset of vitiligo was at any age, ranging from 1 to 74 years old. The average age of 32.17 + 17.29,72.1% of vitiligo was 11-50 years old, with the largest proportion of 21-30 years old, 19.2%. The proportion of the group less than 10 years old and the 50 year old group was less than 12%. The incidence of female vitiligo in all ages except 11-20 years old was higher than that of men, especially in the stage of 21-60 years, the incidence of women was 3 times more than that of men. The average course of disease was 4.12 + 5.96 years, of which the course of disease was 1 years and 3 years, accounting for 24.04%, 62 cases of 1 years in the course of illness accounted for 59. In.6%.104 patients with vitiligo, there were 80 cases of normal skin color, 19 cases of blacken and 5 cases of whiteness. This study showed that the prevalence rate of black people in the yellow race was higher than that of vitiligo patients in.104 cases, and 100 patients could recall the first onset or this aggravation season, 29 cases in the first onset or this aggravation time, 44 in summer and 14 in the autumn. The incidence of 13 cases in winter was obviously higher than that of autumn and winter in the spring and summer season. At present, the lesions mainly distributed in the face, hand and neck, and the upper limbs of the head and neck of the body. The primary skin lesions were in the face, the hand and the abdomen, and the upper limbs of the head and neck trunk of the upper limbs were.104 cases of white purpura, 4 cases of segmental type and 100 cases of common type. In the 21 cases of progressive period, 21 cases were mainly scattered and acromegaly, 83 cases in the stable period, mainly scattered and localized, 91 cases of complete leukoplakia and 13 cases of incomplete leukoplakia. The severity of skin lesions was mild and moderate. In this study, 12.5% of the patients with white purpura had family history, and the family members had 16 cases. Among them, there were 5, 31.3%, 8, 50%, 3, 18.7%, and class III of relatives lower than I, class II. Among the many related causes, psycho psychological factors accounted for the largest proportion, and 72.12% of vitiligo patients had had mental trauma before the onset of disease or in the relapse stage. There are about 22.12% of vitiligo patients with thyroid diseases, rheumatoid, hepatitis, asthma, alopecia, eczema, diabetes, chronic rhinitis, chronic gastritis and other autoimmune or immune related diseases, and 33.65% of vitiligo patients have homomorphic reactions. Intake of vitamin C, more exposure to computers, television and some chemicals, and the lack of trace elements were all associated risk factors for the disease in.104 patients with vitiligo, 18 cases of qi stagnation and blood stasis, 48 cases of yin deficiency of liver and kidney, 38 cases of other syndrome types, tongue dark red (50%), moss white (54.8%), pulse sinks (47.1%) and sunk chord (35%).
Tutor treatment experience: in view of the various pathogenic factors of vitiligo, the single treatment method is difficult to achieve the ideal effect, the tutor adopts comprehensive therapy to achieve better clinical effect, including syndrome differentiation and treatment of Chinese medicine, medicine soup external application to lead Qi and blood, diet therapy, psychological counseling, sera fixation.
【學(xué)位授予單位】:北京中醫(yī)藥大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2012
【分類號】:R758.41
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 劉志勇;王莒生;;王莒生治療白癜風(fēng)的經(jīng)驗(yàn)[J];北京中醫(yī)藥;2008年12期
2 李雪莉;卡介菌多糖核酸治療白癜風(fēng)的臨床觀察[J];臨床醫(yī)學(xué);2004年03期
3 周平蘭,歐陽恒,王竹鑫;白癜風(fēng)的藥物治療進(jìn)展[J];中醫(yī)藥導(dǎo)報(bào);2005年01期
4 黃惠明,,易誠予;人頭發(fā)鈷含量與白癜風(fēng)[J];江西醫(yī)藥;1995年01期
5 朱鐵君;白癜風(fēng)650例臨床研究[J];臨床皮膚科雜志;1995年05期
6 孫越,韓菁,朱光斗;白癜風(fēng)150例家系調(diào)查[J];臨床皮膚科雜志;2000年03期
7 劉棟,朱文元,譚城;皮質(zhì)類固醇對培養(yǎng)Cloudman S91黑素瘤細(xì)胞株黑素合成的影響[J];臨床皮膚科雜志;2003年01期
8 許定安;1例白癜風(fēng)患者家系的遺傳分析[J];臨床皮膚科雜志;1994年05期
9 石得仁,普雄明,謝風(fēng)蓮;兩種類型白癜風(fēng)患者郎格罕細(xì)胞電鏡觀察[J];臨床皮膚科雜志;1996年03期
10 杜娟,朱鐵君;白癜風(fēng)的超微結(jié)構(gòu)變化[J];臨床皮膚科雜志;1996年04期
相關(guān)碩士學(xué)位論文 前1條
1 陳高飛;白斑Ⅰ方治療白癜風(fēng)的臨床研究[D];廣州中醫(yī)藥大學(xué);2009年
本文編號:2167637
本文鏈接:http://sikaile.net/yixuelunwen/pifb/2167637.html